These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32784356)

  • 1. Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer Drugs.
    Alven S; Aderibigbe BA
    Nanomaterials (Basel); 2020 Aug; 10(8):. PubMed ID: 32784356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide based oral nanocarriers for the improvement of bioavailability and anticancer efficacy of curcumin.
    Chaurasia S; Patel RR; Chaubey P; Kumar N; Khan G; Mishra B
    Carbohydr Polym; 2015 Oct; 130():9-17. PubMed ID: 26076595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin.
    Quiñones JP; Roschger C; Iturmendi A; Henke H; Zierer A; Peniche-Covas C; Brüggemann O
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Therapeutic Efficacy of Dendrimer and Micelle Formulations for Breast Cancer Treatment.
    Alven S; Aderibigbe BA
    Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33333778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles Formulations of Artemisinin and Derivatives as Potential Therapeutics for the Treatment of Cancer, Leishmaniasis and Malaria.
    Alven S; Aderibigbe BA
    Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32784933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
    Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
    Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
    Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
    Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.
    Mohanty C; Das M; Sahoo SK
    Expert Opin Drug Deliv; 2012 Nov; 9(11):1347-64. PubMed ID: 22971222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.
    Ruttala HB; Ko YT
    Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
    Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
    Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer chemotherapy with lipid-based nanocarriers.
    Liu D; Zhang N
    Crit Rev Ther Drug Carrier Syst; 2010; 27(5):371-417. PubMed ID: 21083528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between PLGA-PEG and NIPAAm-MAA nanocarriers in curcumin delivery for hTERT silencing in lung cancer cell line.
    Roointan A; Sharifi-Rad M; Badrzadeh F; Sharifi-Rad J
    Cell Mol Biol (Noisy-le-grand); 2016 Aug; 62(9):51-6. PubMed ID: 27585262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of different nanocarriers for encapsulation of curcumin.
    Rafiee Z; Nejatian M; Daeihamed M; Jafari SM
    Crit Rev Food Sci Nutr; 2019; 59(21):3468-3497. PubMed ID: 30001150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication of electrospun poly(ethylene oxide)-poly(capro lactone) composite nanofibers for co-delivery of niclosamide and silver nanoparticles exhibits enhanced anti-cancer effects in vitro.
    Dubey P; Gopinath P
    J Mater Chem B; 2016 Jan; 4(4):726-742. PubMed ID: 32262954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the Functional Activities of Curcumin Using Milk Proteins as Nanocarriers.
    Taha S; El-Sherbiny I; Enomoto T; Salem A; Nagai E; Askar A; Abady G; Abdel-Hamid M
    Foods; 2020 Jul; 9(8):. PubMed ID: 32722034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid Mesoporous-Microporous Nanocarriers for Overcoming Multidrug Resistance by Sequential Drug Delivery.
    Wang L; Guan H; Wang Z; Xing Y; Zhang J; Cai K
    Mol Pharm; 2018 Jul; 15(7):2503-2512. PubMed ID: 29768014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in oral delivery of anti-cancer prodrugs.
    Jain AK; Jain S
    Expert Opin Drug Deliv; 2016 Dec; 13(12):1759-1775. PubMed ID: 27292717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art.
    Ahmad MZ; Alkahtani SA; Akhter S; Ahmad FJ; Ahmad J; Akhtar MS; Mohsin N; Abdel-Wahab BA
    J Drug Target; 2016; 24(4):273-93. PubMed ID: 26066739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.